期刊文献+

二甲双胍治疗青春期多囊卵巢综合征的疗效分析及安全性评价 被引量:3

The Clinical Effect and Safety of Metformin to Treat Polycystic Ovarian Syndrome
下载PDF
导出
摘要 目的评价二甲双胍治疗青春期多囊卵巢综合征的疗效和安全性。方法 78例患者,分成两组,对照组患者进行优思明治疗,实验组患者进行优思明+二甲双胍治疗。结果实验组患者的多毛、痤疮等临床症状较对照组显著改善,T、LH、FSH、FINS、FPG、BMI指标较对照组显著下降(P<0.05)。结论在优思明治疗的基础上,应用二甲双胍治疗青春期多囊卵巢综合征效果显著,可以改善胰岛素抵抗,减少不良反应。 Objective To evaluate the efficacy and safety of metformin in the treatment of adolescent polycystic ovary syndrome. Methods 78 cases, 39 cases in each. control group were treated with Yasmin treatment, experimental group were Yasmin + dimethyl biguanide treatment. Results The clinical symptoms of patients in the experimental group of hirsutism, acne and other than in the control group improved significantly, t, LH, FSH, fins, FPG, BMI group decreased significantly compared with the control group(P〈0.05). But the adverse reactions of the two groups of patients had no statistical significance, P〉0.05. Conclusion Based Yasmin treatment, application of metformin in the treatment of adolescent polycystic ovary syndrome has better effects can improve insulin resistance and reduce the adverse reactions.
作者 董业芳
出处 《中国继续医学教育》 2015年第18期166-167,共2页 China Continuing Medical Education
关键词 二甲双胍 青春期多囊卵巢综合征 临床疗效 安全性 Metformin Polycystic ovarian syndrome Clinical efficacy Safety
  • 相关文献

参考文献5

二级参考文献36

  • 1李国华,黄薇.二甲双胍在多囊卵巢综合征的应用[J].实用妇产科杂志,2005,21(9):534-537. 被引量:34
  • 2The Rotten dam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Grop. Revised 2003 consensus on diagnostic criteria and long term health risks related to polycystic ovary syndrome (pcos)[J]. Hum Report, 2004, 19(1): 41-47.
  • 3AZZIR R, WOODS KS, REYNA R, et al. The prevalence and features of the polyeystic ovary syndrome in an unselected popu- lation[J]. J Clin Endocrinol Metab, 2004, 89: 2745-2749.
  • 4LEGRO RS, GNATUK CL, KUNSELMAN AR, et al. Changes in glucosetolerance over time in women with polycystic ovary syndrome: a controlled study[J]. J Clin Endocrinol Metab, 2005, 90: 3263-3242.
  • 5FARRELL K, ANTONI MH. Insulin resistance, obesity, inflammation, and depression in polycystic ovary syndrome: biobehavioral mechanisms and interventions[J]. Fertil Steril, 2010, 94: 1565-1574.
  • 6PALOMBA S, FALBO A, ORIOF JR, et al. Efficacy predictors for metformin and clomiphene citrate treatment in anovulatory in- fertile patients with polycystic ovary syndrome[J]. Fertil Steril, 2009, 91: 2557-2567.
  • 7LEGRO RS, BARNHART HX, SCHLAFF WD, et al. Clomiphene mefformin or both for infertility in the polyeystie ovary syndrome [J]. N Engl J Med, 2007, 356: 551-566.
  • 8Glintborg DAndersen M.An update on the pathogenesis,inflammation and metabolism in hirsutism and polycystic ovary syndrome[J].Gynecol Endocrinol,2010,26(4):281-296.
  • 9Franca F,Daria P,Veronica L,et al.Adolescent girls with polycystic ovary syndrome showing different phenotypes have a different metabolic profile associated with increasing an drogen levels[J].Fertil Steril,2009,92(2):626-634.
  • 10Madhavi P,Pervin M,Jyotsna MB,et al.CYP11A1 and CYP17 promoter polymorphisms associate with hyperandrogenemia in polycystic ovary syndrome[J].2009,92(2):653-659.

共引文献24

同被引文献23

引证文献3

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部